|
Market Closed -
Nasdaq
00:00:00 17/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 34.35 USD | +0.38% |
|
-1.21% | -4.26% |
| 08-04 | Indivior Pharmaceuticals, Inc. Enters into Senior Secured Term Loan Facility | CI |
| 08-04 | Indivior Pharmaceuticals, Inc. Proposes Special Cash Dividend | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- INDV Stock
- Consensus Indivior Pharmaceuticals, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
